The excessive production, activation, and release of IL‐1β, IL‐18, and GSDMD have been implicated in the development and progression of numerous autoimmune and inflammatory conditions, including RA, IBD, Parkinson's disease (PD), Alzheimer's disease (AD), and MS [9, 39, 40, 41]. Here, GSDMD is linked to Parkinson disease.